| Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis A Mizbani, T Taheri, F Zahedifard, Y Taslimi, H Azizi, K Azadmanesh, ... Vaccine 28 (1), 53-62, 2009 | 128 | 2009 |
| Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis S Rafati, F Zahedifard, F Nazgouee Vaccine 24 (12), 2169-2175, 2006 | 117 | 2006 |
| Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies A Bolhassani, T Taheri, Y Taslimi, S Zamanilui, F Zahedifard, N Seyed, ... Experimental parasitology 127 (3), 637-645, 2011 | 113 | 2011 |
| Leishmaniasis and various immunotherapeutic approaches Y Taslimi, F Zahedifard, S Rafati Parasitology 145 (4), 497-507, 2018 | 108 | 2018 |
| Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies A Bolhassani, F Zahedifard, M Taghikhani, S Rafati Vaccine 26 (26), 3362-3370, 2008 | 94 | 2008 |
| Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection D Doroud, F Zahedifard, A Vatanara, AR Najafabadi, Y Taslimi, ... Journal of controlled release 153 (2), 154-162, 2011 | 91 | 2011 |
| Enhanced Protective Efficacy of Nonpathogenic Recombinant Leishmania tarentolae Expressing Cysteine Proteinases Combined with a Sand Fly Salivary Antigen F Zahedifard, E Gholami, T Taheri, Y Taslimi, F Doustdari, N Seyed, ... PLoS neglected tropical diseases 8 (3), e2751, 2014 | 84 | 2014 |
| Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis N Saljoughian, T Taheri, F Zahedifard, Y Taslimi, F Doustdari, ... PLoS neglected tropical diseases 7 (4), e2174, 2013 | 78 | 2013 |
| Therapeutic live vaccines as a potential anticancer strategy A Bolhassani, F Zahedifard International journal of cancer 131 (8), 1733-1743, 2012 | 78 | 2012 |
| Cationic solid lipid nanoparticles loaded by cysteine proteinase genes as a novel anti-leishmaniasis DNA vaccine delivery system: characterization and in vitro evaluations. D Doroud, A Vatanara, F Zahedifard, E Gholami, R Vahabpour, ... Journal of Pharmacy and Pharmaceutical Sciences 13 (3), 320-335, 2010 | 74 | 2010 |
| In Silico Analysis of Six Known Leishmania major Antigens and In Vitro Evaluation of Specific Epitopes Eliciting HLA-A2 Restricted CD8 T Cell Response N Seyed, F Zahedifard, S Safaiyan, E Gholami, F Doustdari, ... Plos neglected tropical diseases 5 (9), e1295, 2011 | 73 | 2011 |
| Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals N Khoshgoo, F Zahedifard, H Azizi, Y Taslimi, MJ Alonso, S Rafati Vaccine 26 (46), 5822-5829, 2008 | 62 | 2008 |
| Cationic solid–lipid nanoparticles are as efficient as electroporation in DNA vaccination against visceral leishmaniasis in mice N Saljoughian, F Zahedifard, D Doroud, F Doustdari, M Vasei, ... Parasite Immunology 35 (12), 397-408, 2013 | 60 | 2013 |
| Human neutrophil peptide-1 (HNP-1): a new anti-leishmanial drug candidate S Dabirian, Y Taslimi, F Zahedifard, E Gholami, F Doustdari, ... PLOS Neglected Tropical Diseases 7 (10), e2491, 2013 | 59 | 2013 |
| Protective efficiency of dendrosomes as novel nano-sized adjuvants for DNA vaccination against birch pollen allergy NAB Balenga, F Zahedifard, R Weiss, MN Sarbolouki, J Thalhamer, ... Journal of biotechnology 124 (3), 602-614, 2006 | 59 | 2006 |
| Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB/c mice model A Katebi, E Gholami, T Taheri, F Zahedifard, S Habibzadeh, Y Taslimi, ... Molecular immunology 67 (2), 501-511, 2015 | 53 | 2015 |
| Evaluation of DNA/DNA and prime-boost vaccination using LPG3 against Leishmania major infection in susceptible BALB/c mice and its antigenic properties in human leishmaniasis N Abdian, E Gholami, F Zahedifard, N Safaee, S Rafati Experimental parasitology 127 (3), 627-636, 2011 | 49 | 2011 |
| Comparative study of different forms of Jellein antimicrobial peptide on Leishmania parasite F Zahedifard, H Lee, JH No, M Salimi, N Seyed, A Asoodeh, S Rafati Experimental parasitology 209, 107823, 2020 | 44 | 2020 |
| Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against … M Shahbazi, F Zahedifard, T Taheri, Y Taslimi, S Jamshidi, S Shirian, ... PloS one 10 (7), e0132794, 2015 | 43 | 2015 |
| Cysteine proteinase type I, encapsulated in solid lipid nanoparticles induces substantial protection against Leishmania major infection in C57BL/6 mice D Doroud, F Zahedifard, A Vatanara, AR Najafabadi, S Rafati Parasite Immunology 33 (6), 335-348, 2011 | 43 | 2011 |